Confo Therapeutics
Marc is our Head of Finance and HR.
Prior to joining Confo, Marc was Associate Director of Finance at Argenx from 2010-2016, where he helped professionalize the Company’s Finance and HR department. He was also part of the core-team launching Argenx’ IPO on Euronext Brussels in 2014.
Prior to his Biotech experience, Marc served in several finance positions with increasing responsibility in the Travel Industry (Thomas Cook) and Sportswear (Champion).
Marc holds an Accounting degree and completed the Executive Masterclass Corporate Finance at the Vlerick Management School.
This person is not in any teams
This person is not in any offices
Confo Therapeutics
1 followers
Confo Therapeutics is an emerging drug discovery company built around a disruptive technology to enable the discovery of GPCR agonists. The CONFO® technology uses single domain antibodies to lock inherently unstable GPCRs in the druggable conformation and uses this stabilized complex as a superior starting point for GPCR drug discovery.